Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

26

Full text

18

Free full text

2

Publication Types

Journal Article

28

Review

26

Case Reports

5

Research Support, U.S. Gov't, P.H.S.

3

Research Support, Non-U.S. Gov't

2

Clinical Trial

2

Research Support, N.I.H., Extramural

2

Publication Year

From

To

Quick links

Individual year

2018

2

2014

1

2013

1

2012

1

2010

1

2009

1

2008

1

2007

3

2006

3

2005

1

2004

2

2003

1

2002

3

2001

4

2000

3

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Porphyria Cutanea Tarda""[mesh_terms]

28 Results

Searching titles within these results

Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme.

S Thunell, P Harper

Scandinavian journal of clinical and laboratory investigation 2001;60(7):561-79

The management of porphyria cutanea tarda.

R P Sarkany

Clinical and experimental dermatology 2001;26(3):225-32

Hemochromatosis and porphyria.

Richard W Lambrecht, Herbert L Bonkovsky

Seminars in gastrointestinal disease 2002;13(2):109-19

Porphyria cutanea tarda.

N R Bleasel, G A Varigos

The Australasian journal of dermatology 2000;41(4):197-206; quiz 207-8

Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.

S K Mukerji

Indian journal of experimental biology 2001;38(7):635-42

Molecular mechanisms of dominant expression in porphyria.

M N Badminton, G H Elder

Journal of inherited metabolic disease 2005;28(3):277-86

Dermatologic Manifestations of Chronic Hepatitis C Infection.

Mehmet Sayiner, Pegah Golabi, Zobair M Younossi, Freba Farhat

Clinics in liver disease 2018;21(3):555-564

High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.

Arnaldo Pinelli, Silvio Trivulzio, Livio Tomasoni, Boris Bertolini, Giovanna Pinelli

Pharmacological research 2003;45(4):355-9

Therapy of porphyria cutanea tarda.

Erich Köstler, Uwe Wollina

Expert opinion on pharmacotherapy 2006;6(3):377-83

Porphyrias and photosensitivity: pathophysiology for the clinician.

Loukas Kakoullis, Stylianos Louppides, Eleni Papachristodoulou, George Panos

Postgraduate medicine 2018;130(8):673-686

A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine.

K McKenna, N S Cooke

Clinical and experimental dermatology 2007;32(1):64-6

Iron in nonhemochromatotic liver disorders.

Herbert L Bonkovsky, Vamsee Alla

Seminars in liver disease 2006;25(4):461-72

Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.

S Shieh, J L Cohen, H W Lim

Journal of the American Academy of Dermatology 2000;42(4):645-52

Porphyria cutanea tarda, hepatitis C, alcoholism, and hemochromatosis: a case report and review of the literature.

Hunter Sams, Monika G Kiripolsky, Leena Bhat, George P Stricklin

Cutis 2004;73(3):188-90

Iron overload and cutaneous disease: an emphasis on clinicopathological correlations.

Adam Friedman, Laura Englander

Journal of drugs in dermatology : JDD 2010;9(6):719-22

Results: 1 – 15 / 28

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.